Substituted Xanthine Derivatives
Sun Pharmaceutical Industries, Inc.
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 8 of these applications claim priority to application 12/380,579, filed Feb 27, 2009. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 8,263,601 | Deuterium Substituted Xanthine Derivatives In force · Low confidence UsedRemaining | Sun Pharmaceutical Industries, Inc. | In force | Low confidence | ||
| US 9,035,050 | Substituted Xanthine Derivatives In force · Low confidence | Sun Pharmaceutical Industries, Inc. | In force | Low confidence | ||
| US 9,492,457 | Substituted Xanthine Derivatives In force · Low confidence | Sun Pharmaceutical Industries, Inc. | In force | Low confidence | ||
| US 9,493,463 | Substituted Xanthine Derivatives In force · Low confidence | Sun Pharmaceutical Industries, Inc. | In force | Low confidence | ||
| US 9,918,987 | Substituted Xanthine Derivatives In force · Low confidence | Sun Pharmaceutical Industries, Inc. | In force | Low confidence | ||
| US 10,335,413 | Substituted Xanthine Derivatives In force · Low confidence | Sun Pharmaceutical Industries, Inc. | In force | Low confidence | ||
| US 8,987,442 | Deuterium-Substituted Xanthine Derivatives and Methods of Use In force · Low confidence | Sun Pharmaceutical Industries, Inc. | In force | Low confidence | ||
| US 8,952,016 | Substituted Xanthine Derivatives In force · Medium confidence | Sun Pharmaceutical Industries, Inc. | In force | Medium confidence |
8 of 8 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.